CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, announced that it has appointed Glenn Hassan to the position of Chief Financial Officer and Chief Business Officer, and Gerald F. Cox, MD, PhD, as Chief Development Strategist and interim Chief Medical Officer, effective as of April.
April 16, 2019
· 3 min read